According to an international study led by researchers from the Virginia Commonwealth University (VCU) School of Pharmacy, multiple genes contribute to risk for schizophrenia and appear to function in pathways related to transmission of signals in the brain and immunity [1]. The discovery provides scientists with a better understanding the molecular and biological mechanisms involved with schizophrenia that may improve disease management and identify new drug targets. The study is published in the April issue of JAMA Psychiatry.

Could drug addiction treatment of the future be as simple as an on/off switch in the brain? A study in rats has found that stimulating a key part of the brain reduces compulsive cocaine-seeking and suggests the possibility of changing addictive behavior generally [1]. The study, published in the journal Nature, was conducted by scientists at the Intramural Research Program of the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, and the University of California, San Francisco.

Researchers recently examined the effects of cognitive behavioural therapy (CBT) on brain functioning in depressed patients and found that the psychotherapeutic approach made actual changes in the brain [1]. The study was published in the journal Social Cognitive and Affective Neuroscience.

At the convergence of biotechnology and nanotechnology, a new project to map the active human brain may eventually lead to an understanding of human perception and consciousness, as well as therapies for neurological disorders such as Alzheimer’s disease, schizophrenia and autism.

This week is Brain Awareness Week (BAW), a worldwide week-long celebration of the brain. BAW was founded and is coordinated by the Dana Alliance for Brain Initiatives and European Dana Alliance for the Brain. Every year in March, BAW focuses on increasing public awareness about the progress and benefits of brain research.